![Jing Rong Jean Cui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Rong Jean Cui
Fondateur chez
BLOSSOMHILL THERAPEUTICS, INC.
Profil
Dr. Jing Rong Jean Cui is a President, CEO, Director & Scientific Founder at Blossomhill Therapeutics, Inc. She is on the Board of Directors at Blossomhill Therapeutics, Inc. Dr. Jean Cui also served on the board at Turning Point Therapeutics, Inc. She received her undergraduate degree from the University of Science & Technology of China, a graduate degree from the University of Science & Technology of China and a doctorate degree from The Ohio State University.
Postes actifs de Jing Rong Jean Cui
| Sociétés | Poste | Début |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Fondateur | 01/06/2020 |
Anciens postes connus de Jing Rong Jean Cui
| Sociétés | Poste | Fin |
|---|---|---|
| TURG POIN | Fondateur | 15/06/2020 |
Formation de Jing Rong Jean Cui
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
